Summary. Thirty adult Mule (Blue-faced Leicester \ m=x\Swaledale) ewes were actively immunized against a synthetically produced peptide corresponding to the N-terminus of the \g=a\-subunitof bovine inhibin conjugated to tuberculin purified protein derivative (PPD). Primary immunization in the late anoestrous period was followed by two booster injections at 5 week intervals. Control groups were either not immunized (n = 15) or received PPD only (n = 15). Ten days after the second booster, oestrus was synchronized using progestagen sponges and ovulation rate was assessed by laparoscopy on days 9\p=n-\10of the cycle. Blood samples were taken at the time of each immunization and immediately before laparoscopy. Ewes were mated with fertile rams in midNovember and the resulting conception, pregnancy and lambing rates monitored. All inhibin-immunized ewes generated antibodies that bound 125I-labelled native bovine inhibin (Mr 32 000), and their plasma follicle-stimulating hormone (FSH) concentrations after the second booster were significantly higher than the preimmunization values (30%; P < 0\m=.\001) and the corresponding value in the controls (25%; P < 0\m=.\025). Inhibin immunization was associated with a 90% increase in ovulation rate (P < 0\m=.\005) and had no adverse effect on conception rate (100%), pregnancy rate (100%) or length of gestation (146 days). However, only a 37% increase (P < 0\m=.\05) in lambing rate was recorded for inhibin-immunized ewes, indicating a higher incidence of wastage of ova, or embryos, or both, in these ewes. As a consequence of the increased litter size, mean live birthweight of lambs was significantly lower (18%; P < 0\m=.\001) in the inhibin-immunized group and a higher proportion of the lambs born to inhibinimmunized ewes (15\m=.\4%compared with 0\m=.\02%in controls) were stillborn. Stillborn lambs weighed considerably less (38%; P < 0\m=.\001) than viable lambs. In terms of the number of viable lambs produced, there was no significant difference between the inhibin-immunized and control group. Although this study confirms the effectiveness of inhibin immunization using a synthetic peptide-based vaccine as a reliable method for increasing ovulation rate in sheep, the results indicate the limitations of this technique for further increasing viable litter size in 'improved' breeds of relatively high inherent prolificacy.
Introduction
Various strategies have been used to increase prolificacy in sheep and other domesticated species. In addition to selective breeding programmes (Bradford, 1985) , a number of nongenetic methods have
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received considerable attention including administration of exogenous gonadotrophins such as equine chorionic gonadotrophin (Gheraradi & Lindsay, 1980) , autoimmunization against ovarian steroids by active (Scaramuzzi & Hoskinson, 1984) or passive (Land et al, 1982) immunization and, more recently, autoimmunization against inhibin. Inhibin is a gonadal glycoprotein hormone which exerts a selective, suppressive effect on the secretion of pituitary FSH (Ying, 1988) . As such, it would be anticipated that immunoneutralization of endogenous circulating inhibin would lead to an increase in plasma FSH concentrations which could promote ovarian hyperstimulation, perhaps culminating in an increased ovulation rate. Experiments involving active immunization of sheep against various inhibin-containing preparations including partially purified bovine follicular fluid (Henderson et al, 1984; O'Shea et al, 1984; Cummins et al, 1986; Al-Obaidi et al, 1987) , recombi¬ nant DNA-derived preparations of the inhibin a-subunit (Forage et al, 1987; Tsonis et al, 1989; Mizumachi et al, 1990) and chemically synthesized fragments of inhibin (Wrathall et ai, 1990) have provided convincing evidence to support this theory and have proved conclusively that immu¬ noneutralization of endogenous inhibin can promote a marked increase (2-4-fold) in ovulation rate. However, very little information (Tsonis et al, 1989) is available regarding the impact of inhibin immunization on other critical stages of the reproductive process (including the ability of the ewe to display oestrus, mate, conceive and géstate) and whether the observed increase in ovulation rate is actually reflected by an increase in viable litter size.
The objectives of the present study were (i) to confirm the effectiveness of a synthetic peptidebased inhibin vaccine in generating antibodies to inhibin, raising plasma FSH and increasing ovulation rate in a different (and more typical UK lowland) breed of sheep from that used in our initial study (Wrathall et al, 1990); and (ii) 
Determination of hormone concentrations
Plasma concentrations of FSH were assessed using a homologous ovine FSH radioimmunoassay kit provided by NIDDK (Bethesda, MD, USA). Intra-and interassay coefficients of variation were 7% and 8%, respectively, and the detection limit of the assay expressed as the amount of FSH standard required to inhibit the binding of the iodinated tracer (NIADDK-oFSH-Il) to the antibody (NIADKK-anti-oFSH-1; final dilution 1:16 000) by 20% was 37 pg per tube (equivalent to 0-37 pgl"1).
Determination of plasma concentrations of LH was made using the radioimmunoassay described by Walton et ai (1977) . Intra-and interassay coefficients of variation were 9% and 13%, respectively. 
Results
In December, one ewe from the inhibin-immunized group died (cause of death not established) and one of the PPD-immunized animals suffered a fractured leg and hence was excluded from the study.
Plasma anti-inhibin titres and concentrations of FSH and LH
Antibodies that bound 125I-labelled bovine inhibin (Mr32 000) were produced by all ewes receiving the bIa(129)-Tyr30-PPD immunogen, titres rising from very low levels after the first booster to a mean value of 16-3 ± 1 -4% (at 1:1000 dilution) after the second booster injection (Fig.  1) . In neither PPD-immunized nor nonimmunized ewe plasma was any binding of 125I-labelled bovine inhibin detectable above the level seen in nonspecific binding (buffer only) tubes.
The data for PPD-immunized and nonimmunized animals have been combined as there were no significant differences in FSH concentration between these two control groups. A significant increase (30%; < 0001) in mean plasma concentrations of FSH over mean preimmunization levels was seen 10 days after the second booster immunization in inhibin-immunized ewes but not in control animals (Fig. 1) . Concentrations of plasma FSH in inhibin-immunized ewes both 5 weeks after the first booster and 10 days after the second booster immunization were significantly higher (25%, < 0025) than in the corresponding plasma samples from control ewes. In contrast, The results for PPD-immunized (Group 2) and nonimmunized (Group 3) ewes were combined since they did not differ significantly from each other. In both inhibin-immunized and control groups, all ewes were fertilized and subsequently deemed to be pregnant approximately 11 weeks later; only one animal (in the control group) failed to produce at least one lamb (Table 2 ). There was no difference between the two groups in the mean length of gestation. The mean number of lambs born per ewe in the inhibin-immunized group (2-69 + 0-27, range 1-8) was significantly higher (P < 005) than in controls (1 -97 ± 012, range 0-3) (Table 3) , although a higher proportion of lambs in the inhibin-immunized group were born dead (15-4% of the total, compared with 002% in control animals). Consequently, there was no significant difference between the two groups in the number of viable lambs (inhibin-immunized: 2-28 ± 0-21; controls: 1-93 + 0-11; > 005). In addition, mean live birthweight was significantly lower (P < 0001) in the inhibin-immunized group (4-28 + 012 kg) than in controls (5-21 ± 015 kg), whereas within the immunized group itself, lambs born dead weighed significantly less (P < 0001) than those born alive (Table 2) .
Discussion
This study confirms and extends previous reports that active immunization of sheep against inhibin-containing preparations including partially purified bovine follicular fluid (Henderson et al, 1984; O'Shea et al, 1984; Cummins et al, 1986) , recombinant DNA-derived inhibin subunits (Forage et al, 1987; Tsonis et al, 1989; Mizumachi et al, 1990) and chemically synthesized frag¬ ments of inhibin (Wrathall et al, 1990) The present study revealed that active immunization against a synthetic inhibin fragment had no adverse effects on fertility (conception rate) and did not alter mean gestation length (146 days). After introduction offertile rams, all but two ewes (one from each group) conceived at first mating with the remainder conceiving at second mating. It may be assumed, therefore, that all ewes showed behavioural oestrus indicative of a normal preovulatory positive feedback relationship between oestradiol and LH. Ultrasonic scanning at approximately 11 weeks' gestation provided confir¬ mation that all immunized and control ewes were pregnant although it was not possible to ascertain the number of fetuses per ewe when this was judged to exceed two. All ewes, with the exception of one from the control group, gave birth to at least one lamb, mean lambing rate being 37% greater (P < 005) in the inhibin-immunized group than in the controls. It is clear, however, that the pro¬ portion of corpora lutea that resulted in lambs was considerably less for inhibin-immunized (70%) than for control (95%) ewes (see Table 2 ). This indicates a greater incidence of wastage of ova, embryos, or both, in the inhibin-immunized group, which is presumed to be a direct consequence of the substantially higher (90%) ovulation rate shown by these ewes and not due to any adverse effect of inhibin immunoneutralization per se. In support of this view, Ashworth et al ( 1989) 
